Education
About Us
Working with TipRanks
Follow Us
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H (HK:1858)
:1858
1858 Stock Chart & Stats
HK$15.39
-HK$0.21(-2.63%)
At close: 4:00 PM EST
HK$15.39
-HK$0.21(-2.63%)
Day’s Range― - ―
52-Week RangeHK$8.25 - HK$20.82
Previous CloseN/A
Volume218.00K
Average Volume (3M)1.20M
Market Cap
HK$8.59B
Enterprise ValueHK$7.34B
Total Cash (Recent Filing)HK$2.00B
Total Debt (Recent Filing)HK$218.59K
Price to Earnings (P/E)19.3
Beta1.19
Next Earnings
Mar 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.88%
Share Statistics
EPS (TTM)0.22
Shares Outstanding95,140,500
10 Day Avg. Volume978,626
30 Day Avg. Volume1,198,522
Financial Highlights & Ratios
PEG Ratio-0.45
Price to Book (P/B)1.08
Price to Sales (P/S)3.77
P/FCF Ratio-59.48
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetExceptionally low leverage materially reduces refinancing and solvency risk, giving management durable financial flexibility to fund R&D, capex or strategic M&A from cash. This lowers downside in cyclical healthcare demand and supports long-term operational stability.
Strong TTM Revenue And MarginsSustained double-digit TTM revenue growth combined with high gross and healthy net margins indicates pricing power and favorable product mix in medical devices. These durable margin profiles enable reinvestment and create lasting incremental profitability as sales scale.
Positive Trailing Free Cash FlowPositive trailing free cash flow of ~127M, representing a meaningful share of net income, shows the business generates real cash to fund capex, dividends or strategic spending. Over the medium term this FCF provides structural optionality and a buffer in downturns.
Bears Say
Volatile Cash GenerationMaterial swings from strong cash in 2023 to negative operating and free cash flow in 2024 signal volatility in cash generation. This undermines reliable internal funding for growth, complicates multi-year planning, and raises the probability of needing external financing in stress periods.
Margin Durability RiskA downward trend from prior peak margins suggests structural pressures—competitive pricing, cost inflation, or adverse mix—that could reduce long-term profitability. If these trends persist, reinvestment capacity and return targets could be harder to sustain.
Weak Cash ConversionOperating cash flow at roughly 43% of reported earnings indicates weak income-to-cash conversion driven by working capital or non-cash items. Persistent low conversion constrains organic funding, increases reliance on balance-sheet liquidity, and reduces resilience to shocks.
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H News
1858 FAQ
What was Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s price range in the past 12 months?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H lowest stock price was HK$8.25 and its highest was HK$20.82 in the past 12 months.
What is Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s market cap?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s market cap is HK$8.59B.
When is Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s upcoming earnings report date?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s upcoming earnings report date is Mar 31, 2026 which is in 37 days.
How were Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s earnings last quarter?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H released its earnings results on Oct 30, 2025. The company reported HK$0.22 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.22.
Is Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H overvalued?
According to Wall Street analysts Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s price is currently Overvalued.
Does Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H pay dividends?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H pays a Semiannually dividend of HK$0.23 which represents an annual dividend yield of 1.88%. See more information on Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H dividends here
What is Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s EPS estimate?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H have?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H has 95,140,500 shares outstanding.
What happened to Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H’s price movement after its last earnings report?
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H reported an EPS of HK$0.22 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -5.977%.
Which hedge fund is a major shareholder of Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:1858
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
99.89%
12-Months-Change
Fundamentals
Return on Equity
8.69%
Trailing 12-Months
Asset Growth
-2.09%
Trailing 12-Months
Company Description
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H
Beijing Chunlizhengda Medical Instruments Co., Ltd., an orthopedic medical device company, engages in the research and development, production, and sale of surgical implants, instruments, and related products in the People's Republic of China. It offers implantable orthopedic medical devices, which consist of joint prosthesis products and spinal products. The company primarily sells its products through distributors, or on ODM and OEM bases under the Chunli brand, as well as to hospitals directly. It also exports its products to various countries. The company was incorporated in 1998 and is headquartered in Beijing, China.
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H (1858) Earnings & Revenues
Technical Analysis
Peijia Medical Ltd.
―
Zylox-Tonbridge Medical Technology Co., Ltd. Class H
―
LifeTech Scientific Corporation
―
China Isotope & Radiation Corp.
―
AK Medical Holdings Ltd.
―
Options Prices
Currently, No data available
---